BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20463295)

  • 1. Poly ADP-ribose polymerase-1 and health.
    Kirkland JB
    Exp Biol Med (Maywood); 2010 May; 235(5):561-8. PubMed ID: 20463295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Niacin and carcinogenesis.
    Kirkland JB
    Nutr Cancer; 2003; 46(2):110-8. PubMed ID: 14690785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between carcinogenesis, chromatin structure and poly(ADP-ribosylation) (review).
    Boulikas T
    Anticancer Res; 1991; 11(2):489-527. PubMed ID: 1905900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
    Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
    J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.
    Pogrebniak A; Schemainda I; Pelka-Fleischer R; Nüssler V; Hasmann M
    Eur J Med Res; 2003 Oct; 8(10):438-50. PubMed ID: 14594650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors.
    Jagtap P; Szabó C
    Nat Rev Drug Discov; 2005 May; 4(5):421-40. PubMed ID: 15864271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the enzymatic catalysis of poly(ADP-ribose) polymerase by dsDNA, polyamines, Mg2+, Ca2+, histones H1 and H3, and ATP.
    Kun E; Kirsten E; Mendeleyev J; Ordahl CP
    Biochemistry; 2004 Jan; 43(1):210-6. PubMed ID: 14705947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ADP-ribose) polymerase as a drug target for cardiovascular disease and cancer: an update.
    Horvath EM; Szabó C
    Drug News Perspect; 2007 Apr; 20(3):171-81. PubMed ID: 17520094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARP inhibitors: new tools to protect from inflammation.
    Giansanti V; Donà F; Tillhon M; Scovassi AI
    Biochem Pharmacol; 2010 Dec; 80(12):1869-77. PubMed ID: 20417190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of poly(ADP-ribosylation) in apoptotic cells.
    Ivana Scovassi A; Diederich M
    Biochem Pharmacol; 2004 Sep; 68(6):1041-7. PubMed ID: 15313399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [PARP inhibitors for cancer therapy].
    Saito H; Miki Y
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):12-8. PubMed ID: 21368455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ADP-ribose) polymerases: homology, structural domains and functions. Novel therapeutical applications.
    Nguewa PA; Fuertes MA; Valladares B; Alonso C; Pérez JM
    Prog Biophys Mol Biol; 2005 May; 88(1):143-72. PubMed ID: 15561303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential contribution of poly(ADP-ribose)polymerase-1 and -2 (PARP-1 and -2) to the poly(ADP-ribosyl)ation reaction in rat primary spermatocytes.
    Tramontano F; Malanga M; Quesada P
    Mol Hum Reprod; 2007 Nov; 13(11):821-8. PubMed ID: 17766683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiology and pathophysiology of poly(ADP-ribosyl)ation.
    Bürkle A
    Bioessays; 2001 Sep; 23(9):795-806. PubMed ID: 11536292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors.
    Putt KS; Hergenrother PJ
    Anal Biochem; 2004 Mar; 326(1):78-86. PubMed ID: 14769338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Poly(ADP-ribose) polymerase-1 as a regulator of protein-nucleic acid interactions in the processes responding to genotoxic action].
    Sukhanova MV; Lavrik OI; Khodyreva SN
    Mol Biol (Mosk); 2004; 38(5):834-47. PubMed ID: 15554186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the expression or recruitment of components of the DNA synthesome by poly(ADP-ribose) polymerase.
    Simbulan-Rosenthal CM; Rosenthal DS; Boulares AH; Hickey RJ; Malkas LH; Coll JM; Smulson ME
    Biochemistry; 1998 Jun; 37(26):9363-70. PubMed ID: 9649317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of poly(ADP-ribose) polymerase increase antibody class switching.
    Shockett P; Stavnezer J
    J Immunol; 1993 Dec; 151(12):6962-76. PubMed ID: 8258703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuronal death: potential role of the nuclear enzyme, poly (ADP-ribose) polymerase].
    Boulu RG; Mesenge C; Charriaut-Marlangue C; Verrecchia C; Plotkine M
    Bull Acad Natl Med; 2001; 185(3):555-63; discussion 564-5. PubMed ID: 11501263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-mitochondrial poly(ADP-ribosyl)ation: potential role for alpha-ketoglutarate dehydrogenase.
    Pankotai E; Lacza Z; Murányi M; Szabó C
    Mitochondrion; 2009 Apr; 9(2):159-64. PubMed ID: 19460292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.